The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glaucoma Treatment Market Research Report 2024
Synopsis
Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.
The global Glaucoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the Hong Kong market, the main Glaucoma Treatment players include Novartis, Allergan, Pfizer, Akorn, etc. The top four Glaucoma Treatment players account for approximately 60% of the total global market. In terms of Product, Prostaglandin Analogs (PGAs) is the largest segment with a share of 52%. And in terms of Applications, the largest segment is Clinic, followed by Pharmacy.
This report aims to provide a comprehensive presentation of the global market for Glaucoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Treatment.
Report Scope
The Glaucoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glaucoma Treatment market comprehensively. Regional market sizes, concerning products by Product, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Product, by Application, and by regions.
Market Segmentation
By Company
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Segment by Product
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others
Segment by Application
Clinic
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Product, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glaucoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.
The global Glaucoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the Hong Kong market, the main Glaucoma Treatment players include Novartis, Allergan, Pfizer, Akorn, etc. The top four Glaucoma Treatment players account for approximately 60% of the total global market. In terms of Product, Prostaglandin Analogs (PGAs) is the largest segment with a share of 52%. And in terms of Applications, the largest segment is Clinic, followed by Pharmacy.
This report aims to provide a comprehensive presentation of the global market for Glaucoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Treatment.
Report Scope
The Glaucoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glaucoma Treatment market comprehensively. Regional market sizes, concerning products by Product, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Product, by Application, and by regions.
Market Segmentation
By Company
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Segment by Product
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others
Segment by Application
Clinic
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Product, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glaucoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Product
1.2.1 Global Glaucoma Treatment Market Size Growth Rate by Product: 2019 VS 2023 VS 2030
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Beta Blocker
1.2.4 Alpha Agonist
1.2.5 Others
1.3 Market by Application
1.3.1 Global Glaucoma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glaucoma Treatment Market Perspective (2019-2030)
2.2 Glaucoma Treatment Growth Trends by Region
2.2.1 Global Glaucoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glaucoma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Glaucoma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Glaucoma Treatment Market Dynamics
2.3.1 Glaucoma Treatment Industry Trends
2.3.2 Glaucoma Treatment Market Drivers
2.3.3 Glaucoma Treatment Market Challenges
2.3.4 Glaucoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glaucoma Treatment Players by Revenue
3.1.1 Global Top Glaucoma Treatment Players by Revenue (2019-2024)
3.1.2 Global Glaucoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Glaucoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glaucoma Treatment Revenue
3.4 Global Glaucoma Treatment Market Concentration Ratio
3.4.1 Global Glaucoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Treatment Revenue in 2023
3.5 Glaucoma Treatment Key Players Head office and Area Served
3.6 Key Players Glaucoma Treatment Product Solution and Service
3.7 Date of Enter into Glaucoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glaucoma Treatment Breakdown Data by Product
4.1 Global Glaucoma Treatment Historic Market Size by Product (2019-2024)
4.2 Global Glaucoma Treatment Forecasted Market Size by Product (2025-2030)
5 Glaucoma Treatment Breakdown Data by Application
5.1 Global Glaucoma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Glaucoma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glaucoma Treatment Market Size (2019-2030)
6.2 North America Glaucoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glaucoma Treatment Market Size by Country (2019-2024)
6.4 North America Glaucoma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glaucoma Treatment Market Size (2019-2030)
7.2 Europe Glaucoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glaucoma Treatment Market Size by Country (2019-2024)
7.4 Europe Glaucoma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glaucoma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Glaucoma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glaucoma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Glaucoma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glaucoma Treatment Market Size (2019-2030)
9.2 Latin America Glaucoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glaucoma Treatment Market Size by Country (2019-2024)
9.4 Latin America Glaucoma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glaucoma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Glaucoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glaucoma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Glaucoma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Glaucoma Treatment Introduction
11.1.4 Novartis Revenue in Glaucoma Treatment Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Glaucoma Treatment Introduction
11.2.4 Allergan Revenue in Glaucoma Treatment Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Glaucoma Treatment Introduction
11.3.4 Pfizer Revenue in Glaucoma Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Akorn
11.4.1 Akorn Company Detail
11.4.2 Akorn Business Overview
11.4.3 Akorn Glaucoma Treatment Introduction
11.4.4 Akorn Revenue in Glaucoma Treatment Business (2019-2024)
11.4.5 Akorn Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Glaucoma Treatment Introduction
11.5.4 Teva Revenue in Glaucoma Treatment Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Bausch & Lomb
11.6.1 Bausch & Lomb Company Detail
11.6.2 Bausch & Lomb Business Overview
11.6.3 Bausch & Lomb Glaucoma Treatment Introduction
11.6.4 Bausch & Lomb Revenue in Glaucoma Treatment Business (2019-2024)
11.6.5 Bausch & Lomb Recent Development
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Detail
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Glaucoma Treatment Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2019-2024)
11.7.5 Otsuka Pharmaceutical Recent Development
11.8 Santen
11.8.1 Santen Company Detail
11.8.2 Santen Business Overview
11.8.3 Santen Glaucoma Treatment Introduction
11.8.4 Santen Revenue in Glaucoma Treatment Business (2019-2024)
11.8.5 Santen Recent Development
11.9 Lunan Pharma
11.9.1 Lunan Pharma Company Detail
11.9.2 Lunan Pharma Business Overview
11.9.3 Lunan Pharma Glaucoma Treatment Introduction
11.9.4 Lunan Pharma Revenue in Glaucoma Treatment Business (2019-2024)
11.9.5 Lunan Pharma Recent Development
11.10 Zizhu Pharma
11.10.1 Zizhu Pharma Company Detail
11.10.2 Zizhu Pharma Business Overview
11.10.3 Zizhu Pharma Glaucoma Treatment Introduction
11.10.4 Zizhu Pharma Revenue in Glaucoma Treatment Business (2019-2024)
11.10.5 Zizhu Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
